The self-renewal, growth, and invasion capacity of CSCs can drive malignant transformation [32], thus ENO1-mediated enhancement of these aggressive phenotypes of LCSCs would promote the lung cancer progression. This evidence concerns the gene ENO1 and lung carcinoma.